Table 1 Demographic characteristics of AMD-patients treated at the Brazilian public health system since 2014, and the follow-up period of treatment
Brazil | North | Northeast | Central-West | Southeast | South | |
|---|---|---|---|---|---|---|
AMD-patients, N (%) | 23,031 | 261 (1.1) | 628 (2.7) | 354 (1.5) | 20,049 (87.1) | 1739 (7.6) |
AMD patients per 100,000 older adultsa | 79 | 16 | 9 | 19 | 146 | 36 |
Age (years), mean (SD) | 72.45 (7.39) | 70.38 (7.38) | 71.28 (7.19) | 72.10 (7.70) | 72.66 (7.37) | 72.20 (7.46) |
Age strata, N (%) | ||||||
≤ 50 years-old | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
51- 60 years-old | 27 (0.1) | 10 (2.1) | 4 (0.3) | 1 (0.2) | 11 (0.1) | 1 (0.01) |
61-70 years-old | 10,329 (44.9) | 273 (56.5) | 775 (50.2) | 266 (47.4) | 7573 (43.5) | 1442 (47.5) |
71-80 years-old | 9091 (39.5) | 143 (10.8) | 588 (38.1) | 208 (37.1) | 7019 (40.3) | 1133 (37.3) |
81-90 years-old | 3285 (14.3) | 52 (10.8) | 162 (10.5) | 80 (14.3) | 2566 (14.7) | 425 (14.0) |
≥ 91 years-old | 299 (1.3) | 5 (1.0) | 16 (1.0) | 6 (1.1) | 236 (1.4) | 36 (1.2) |
Female, N (%) | 13,615 (59.1) | 141 (54.0) | 370 (58.9) | 196 (55.4) | 11,846 (59.1) | 1062 (61.1) |
Race, N (%) | ||||||
White | 14,182 (61.6) | 161 (61.7) | 401 (63.9) | 206 (58.2) | 1233 (61.5) | 1081 (62.2) |
Mixed | 3300 (14.3) | 36 (13.8) | 91 (14.5) | 43 (12.1) | 2864 (14.3) | 266 (15.3) |
Black | 5549 (24.1) | 64 (24.5) | 136 (21.7) | 105 (29.7) | 4852 (24.2) | 392 (22.5) |
Follow-up of treated patientsb (N = 1460) | ||||||
Follow-upb (years), mean (SD) | 0.73 (0.88) | 0.57 (0.50) | 0.79 (0.97) | 0.57 (0.34) | ||
Follow-up stratab, N (%) | ||||||
< 6 months | 660 (45.2) | 25 (49.0) | 533 (46.9) | 102 (37.5) | ||
6-12 months | 616 (42.2) | 24 (47.1) | 426 (37.5) | 166 (61.0) | ||
1-2 years | 77 (5.3) | – | 74 (6.5) | – | ||
> 2 years | 43 (2.9) | 2 (3.9) | 40 (3.5) | 1 (0.4) | ||
> 3 years | 64 (4.4) | – | 64 (5.6) | – | ||
Follow-up of non-treated patientsb (N = 21,571) | ||||||
Follow-upb (years), mean (SD) | 0.36 (0.66) | 0.25 (0.30) | 0.25 (0.57) | 0.16 (0.20) | 0.41 (0.72) | 0.26 (0.30) |
Follow-up stratab, N (%) | ||||||
< 6 months | 16,177 (75.0) | 471 (92.4) | 1379 (89.3) | 368 (76.2) | 11,716 (72.0) | 2243 (81.1) |
6-12 months | 4406 (20.4) | 38 (7.5) | 132 (8.5) | 111 (23.0) | 3610 (22.2) | 515 (18.6) |
1-2 years | 371 (1.7) | 1 (0.2) | 3 (0.2) | 3 (0.6) | 363 (2.2) | 1 (0.0) |
2-3 years | 231 (1.1) | – | 4 (0.3) | 1 (0.2) | 224 (1.4) | 2 (0.1) |
> 3 years | 386 (1.8) | – | 27 (1.7) | – | 355 (2.2) | 4 (0.1) |